Promedior (Malvern, PA), a clinical-stage biotechnology company focused on Age-Related Macular Degeneration, closed a $3M Series D financing, bringing the total round to $24.5M. Participants include Shire Strategic Investment Group, Fibrotec Ventures, Morgenthaler Ventures, HealthCare Ventures, Polaris Venture Partners, Forbion Capital Partners and Easton Capital Investment Group.

Collective IP | The Most Comprehensive and Accurate View of Global Innovation and Organization of the International Technology Transfer Office Ecosystem

Request Collective IP Account Access HERE